Acquisition by Rosgen Steven T. of 10000 shares of ImmuCell at 3.6 subject to Rule 16b-3
| ICCC Stock | USD 5.44 0.04 0.74% |
About 52% of ImmuCell's shareholders are presently thinking to get in. The analysis of overall sentiment of trading ImmuCell stock suggests that some investors are interested at this time. The current market sentiment, together with ImmuCell's historical and current headlines, can help investors time the market. In addition, many technical investors use ImmuCell stock news signals to limit their universe of possible portfolio assets.
ImmuCell |
Filed transaction by ImmuCell Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
ImmuCell Fundamental Analysis
We analyze ImmuCell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ImmuCell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ImmuCell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
ImmuCell is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
ImmuCell Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ImmuCell stock to make a market-neutral strategy. Peer analysis of ImmuCell could also be used in its relative valuation, which is a method of valuing ImmuCell by comparing valuation metrics with similar companies.
Peers
ImmuCell Related Equities
| TPST | Tempest Therapeutics | 5.56 | ||||
| LCTX | Lineage Cell | 5.00 | ||||
| HCWB | HCW Biologics | 3.85 | ||||
| ANEB | Anebulo Pharmaceuticals | 3.25 | ||||
| CVKD | Cadrenal Therapeutics, | 2.64 | ||||
| MNOV | MediciNova | 1.49 | ||||
| FENC | Fennec Pharmaceuticals | 1.24 | ||||
| ACOGF | Alpha Cognition | 0.94 | ||||
| RZLT | Rezolute | 0.77 | ||||
| LIPO | Lipella Pharmaceuticals | 0.37 | ||||
| XOMAO | XOMA | 0.12 | ||||
| TRGNF | Transgene | 0.00 | ||||
| ONTTF | Oxford Nanopore | 1.09 | ||||
| PTIX | Protagenic Therapeutics | 9.52 |
Complementary Tools for ImmuCell Stock analysis
When running ImmuCell's price analysis, check to measure ImmuCell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmuCell is operating at the current time. Most of ImmuCell's value examination focuses on studying past and present price action to predict the probability of ImmuCell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmuCell's price. Additionally, you may evaluate how the addition of ImmuCell to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |